ELV — Elevance Health, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
Measured signals that fired on ELV
| date | signal | measured base rate |
|---|---|---|
| 2026-07-28 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-15 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-02 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-02 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-11 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-05 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-17 | BOUDREAUX GAIL President and CEO | Open-market purchase | 2.0K | 368.25 | 753.1K |
| 2026-07-17 | PERU RAMIRO G Director | Open-market purchase | 1.0K | 366.05 | 366.1K |
| 2026-07-17 | BOUDREAUX GAIL President and CEO | Open-market purchase | 680 | 366.41 | 249.2K |
| 2026-06-12 | Penczek Ronald W CAO & Controller | Open-market sale | 369 | 403.16 | 148.8K |
| 2026-06-11 | Dixon Robert L JR Director | Open-market sale | 151 | 401.77 | 60.7K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Open-market sale | 1.5K | 403.13 | 617.2K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Option exercise | 877 | 311.48 | 273.2K |
| 2026-05-19 | Penczek Ronald W CAO & Controller | Option exercise | 654 | 271.27 | 177.4K |
| 2026-05-13 | DeVore Susan D. Director | Grant or award | 563 | 0.00 | 0 |
| 2026-05-13 | COLLIS STEVEN H Director | Grant or award | 563 | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 5.8B | 19.9M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2B | 14.3M |
| STATE STREET CORP | 3.0B | 10.3M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.4B | 8.2M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9B | 6.4M |
| Sanders Capital, LLC | 1.7B | 5.9M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5B | 5.2M |
| Artisan Partners Limited Partnership | 1.5B | 5.1M |
| Invesco Ltd. | 1.4B | 4.8M |
| HARRIS ASSOCIATES L P | 1.4B | 4.8M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Elevance Health stock edges toward $400 as Q2 2026 earnings and guidance support valuation - Ad-hoc-news.de · 2026-08-22 · Ad-hoc-news.de
- 10 Health Care Stocks Whale Activity In Today’s Session · 2026-08-18 · benzinga
- Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2 · 2026-08-18 · benzinga
- Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs · 2026-08-14 · benzinga
- Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’ · 2026-08-11 · benzinga
Others in Healthcare
Ask the AI about ELV
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →